Adalimumab improves symptoms and QOL in rheumatoid arthritis

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2002

Schlagwörter:	Adalimumab Active Rheumatoid Arthritis ACR70 Response Adalimumab Recipient Adalimumab Monotherapy

Anmerkung:	© Adis International Ltd 2002

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1367(2002), 1 vom: Dez., Seite 9-11
Übergeordnetes Werk:	volume:1367 ; year:2002 ; number:1 ; month:12 ; pages:9-11

Links:	Volltext

DOI / URN:	10.2165/00128413-200213670-00018

Katalog-ID:	SPR035145560

Internformat


LEADER	01000caa a22002652 4500
001	SPR035145560
003	DE-627
005	20230519230233.0
007	cr uuu---uuuuu
008	201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200213670-00018 \|2 doi
035			\|a (DE-627)SPR035145560
035			\|a (SPR)00128413-200213670-00018-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Adalimumab improves symptoms and QOL in rheumatoid arthritis
264		1	\|c 2002
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2002
650		4	\|a Adalimumab \|7 (dpeaa)DE-He213
650		4	\|a Active Rheumatoid Arthritis \|7 (dpeaa)DE-He213
650		4	\|a ACR70 Response \|7 (dpeaa)DE-He213
650		4	\|a Adalimumab Recipient \|7 (dpeaa)DE-He213
650		4	\|a Adalimumab Monotherapy \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1367(2002), 1 vom: Dez., Seite 9-11 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1367 \|g year:2002 \|g number:1 \|g month:12 \|g pages:9-11
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200213670-00018 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 1367 \|j 2002 \|e 1 \|c 12 \|h 9-11

Indexfelder

matchkey_str	article:22306056:2002----::dlmmbmrvsyposnqlnhu
hierarchy_sort_str	2002
publishDate	2002
allfields	10.2165/00128413-200213670-00018 doi (DE-627)SPR035145560 (SPR)00128413-200213670-00018-e DE-627 ger DE-627 rakwb eng Adalimumab improves symptoms and QOL in rheumatoid arthritis 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Adalimumab (dpeaa)DE-He213 Active Rheumatoid Arthritis (dpeaa)DE-He213 ACR70 Response (dpeaa)DE-He213 Adalimumab Recipient (dpeaa)DE-He213 Adalimumab Monotherapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1367(2002), 1 vom: Dez., Seite 9-11 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1367 year:2002 number:1 month:12 pages:9-11 https://dx.doi.org/10.2165/00128413-200213670-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1367 2002 1 12 9-11
spelling	10.2165/00128413-200213670-00018 doi (DE-627)SPR035145560 (SPR)00128413-200213670-00018-e DE-627 ger DE-627 rakwb eng Adalimumab improves symptoms and QOL in rheumatoid arthritis 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Adalimumab (dpeaa)DE-He213 Active Rheumatoid Arthritis (dpeaa)DE-He213 ACR70 Response (dpeaa)DE-He213 Adalimumab Recipient (dpeaa)DE-He213 Adalimumab Monotherapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1367(2002), 1 vom: Dez., Seite 9-11 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1367 year:2002 number:1 month:12 pages:9-11 https://dx.doi.org/10.2165/00128413-200213670-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1367 2002 1 12 9-11
allfields_unstemmed	10.2165/00128413-200213670-00018 doi (DE-627)SPR035145560 (SPR)00128413-200213670-00018-e DE-627 ger DE-627 rakwb eng Adalimumab improves symptoms and QOL in rheumatoid arthritis 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Adalimumab (dpeaa)DE-He213 Active Rheumatoid Arthritis (dpeaa)DE-He213 ACR70 Response (dpeaa)DE-He213 Adalimumab Recipient (dpeaa)DE-He213 Adalimumab Monotherapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1367(2002), 1 vom: Dez., Seite 9-11 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1367 year:2002 number:1 month:12 pages:9-11 https://dx.doi.org/10.2165/00128413-200213670-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1367 2002 1 12 9-11
allfieldsGer	10.2165/00128413-200213670-00018 doi (DE-627)SPR035145560 (SPR)00128413-200213670-00018-e DE-627 ger DE-627 rakwb eng Adalimumab improves symptoms and QOL in rheumatoid arthritis 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Adalimumab (dpeaa)DE-He213 Active Rheumatoid Arthritis (dpeaa)DE-He213 ACR70 Response (dpeaa)DE-He213 Adalimumab Recipient (dpeaa)DE-He213 Adalimumab Monotherapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1367(2002), 1 vom: Dez., Seite 9-11 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1367 year:2002 number:1 month:12 pages:9-11 https://dx.doi.org/10.2165/00128413-200213670-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1367 2002 1 12 9-11
allfieldsSound	10.2165/00128413-200213670-00018 doi (DE-627)SPR035145560 (SPR)00128413-200213670-00018-e DE-627 ger DE-627 rakwb eng Adalimumab improves symptoms and QOL in rheumatoid arthritis 2002 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2002 Adalimumab (dpeaa)DE-He213 Active Rheumatoid Arthritis (dpeaa)DE-He213 ACR70 Response (dpeaa)DE-He213 Adalimumab Recipient (dpeaa)DE-He213 Adalimumab Monotherapy (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1367(2002), 1 vom: Dez., Seite 9-11 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1367 year:2002 number:1 month:12 pages:9-11 https://dx.doi.org/10.2165/00128413-200213670-00018 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1367 2002 1 12 9-11
language	English
source	Enthalten in Inpharma weekly 1367(2002), 1 vom: Dez., Seite 9-11 volume:1367 year:2002 number:1 month:12 pages:9-11
sourceStr	Enthalten in Inpharma weekly 1367(2002), 1 vom: Dez., Seite 9-11 volume:1367 year:2002 number:1 month:12 pages:9-11
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Adalimumab Active Rheumatoid Arthritis ACR70 Response Adalimumab Recipient Adalimumab Monotherapy
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2002-12-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035145560
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035145560</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519230233.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213670-00018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035145560</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213670-00018-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adalimumab improves symptoms and QOL in rheumatoid arthritis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adalimumab</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Active Rheumatoid Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ACR70 Response</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adalimumab Recipient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adalimumab Monotherapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1367(2002), 1 vom: Dez., Seite 9-11</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1367</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:9-11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213670-00018</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1367</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">12</subfield><subfield code="h">9-11</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Adalimumab improves symptoms and QOL in rheumatoid arthritis Adalimumab (dpeaa)DE-He213 Active Rheumatoid Arthritis (dpeaa)DE-He213 ACR70 Response (dpeaa)DE-He213 Adalimumab Recipient (dpeaa)DE-He213 Adalimumab Monotherapy (dpeaa)DE-He213
topic	misc Adalimumab misc Active Rheumatoid Arthritis misc ACR70 Response misc Adalimumab Recipient misc Adalimumab Monotherapy
spellingShingle	misc Adalimumab misc Active Rheumatoid Arthritis misc ACR70 Response misc Adalimumab Recipient misc Adalimumab Monotherapy Adalimumab improves symptoms and QOL in rheumatoid arthritis
topic_unstemmed	misc Adalimumab misc Active Rheumatoid Arthritis misc ACR70 Response misc Adalimumab Recipient misc Adalimumab Monotherapy
topic_browse	misc Adalimumab misc Active Rheumatoid Arthritis misc ACR70 Response misc Adalimumab Recipient misc Adalimumab Monotherapy
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Adalimumab improves symptoms and QOL in rheumatoid arthritis
ctrlnum	(DE-627)SPR035145560 (SPR)00128413-200213670-00018-e
title_full	Adalimumab improves symptoms and QOL in rheumatoid arthritis
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2002
contenttype_str_mv	txt
container_start_page	9
container_volume	1367
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200213670-00018
title_sort	adalimumab improves symptoms and qol in rheumatoid arthritis
title_auth	Adalimumab improves symptoms and QOL in rheumatoid arthritis
abstract	© Adis International Ltd 2002
abstractGer	© Adis International Ltd 2002
abstract_unstemmed	© Adis International Ltd 2002
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Adalimumab improves symptoms and QOL in rheumatoid arthritis
url	https://dx.doi.org/10.2165/00128413-200213670-00018
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200213670-00018
up_date	2024-07-03T13:44:24.472Z
_version_	1803565677394526208
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035145560</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519230233.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2002 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200213670-00018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035145560</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200213670-00018-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Adalimumab improves symptoms and QOL in rheumatoid arthritis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2002</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adalimumab</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Active Rheumatoid Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ACR70 Response</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adalimumab Recipient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adalimumab Monotherapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1367(2002), 1 vom: Dez., Seite 9-11</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1367</subfield><subfield code="g">year:2002</subfield><subfield code="g">number:1</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:9-11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200213670-00018</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1367</subfield><subfield code="j">2002</subfield><subfield code="e">1</subfield><subfield code="c">12</subfield><subfield code="h">9-11</subfield></datafield></record></collection>
score	7.4004908

Nicht das Richtige dabei?

Schreiben Sie uns!

Adalimumab improves symptoms and QOL in rheumatoid arthritis

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?